| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |